STOCK TITAN

[8-K] Core Scientific, Inc. Tranche 2 Warrants Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Core Scientific, Inc. furnished a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. The press release is provided as Exhibit 99.1 to this Current Report and is incorporated by reference into Items 2.02 and 7.01 of the filing. The company states that the information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference in Securities Act filings.

The 8-K itself does not include the underlying financial metrics or operational detail; readers must review Exhibit 99.1 for the actual results. The filing also lists the registrant's exchange-listed securities: common stock CORZ and warrants CORZW and CORZZ.

Core Scientific, Inc. ha diramato un comunicato stampa con i risultati finanziari del secondo trimestre fiscale chiuso il 30 giugno 2025. Il comunicato è fornito come Exhibit 99.1 al presente Current Report ed è incorporato per riferimento nelle voci 2.02 e 7.01 della registrazione. La società dichiara che le informazioni contenute nelle voci 2.02 e 7.01, incluso l'Exhibit 99.1, sono furnished e non devono essere considerate 'filed' ai fini della Sezione 18 dello Exchange Act, né incorporate per riferimento in documenti ai sensi dello Securities Act.

L'8-K in sé non riporta i dati finanziari dettagliati o le informazioni operative sottostanti; per i risultati effettivi occorre consultare l'Exhibit 99.1. Il deposito indica inoltre i titoli quotati dell'emittente: azioni ordinarie CORZ e warrant CORZW e CORZZ.

Core Scientific, Inc. difundió un comunicado de prensa con sus resultados financieros del segundo trimestre fiscal finalizado el 30 de junio de 2025. El comunicado se suministra como Exhibit 99.1 a este Current Report y se incorpora por referencia en los ítems 2.02 y 7.01 del expediente. La compañía indica que la información en los ítems 2.02 y 7.01, incluido el Exhibit 99.1, se considera furnished y no debe ser considerada 'filed' a los efectos de la Sección 18 del Exchange Act, ni incorporada por referencia en presentaciones bajo el Securities Act.

El formulario 8-K en sí no contiene las métricas financieras subyacentes ni los detalles operativos; los lectores deben revisar el Exhibit 99.1 para conocer los resultados reales. El informe también enumera los valores cotizados del registrante: acciones ordinarias CORZ y warrants CORZW y CORZZ.

Core Scientific, Inc.는 2025년 6월 30일로 종료된 회계연도 제2분기 재무실적을 알리는 보도자료를 제공했습니다. 해당 보도자료는 본 Current Report의 Exhibit 99.1로 첨부되어 있으며, 제출서류의 항목 2.02 및 7.01에 참조로 포함됩니다. 회사는 항목 2.02 및 7.01에 포함된 정보(및 Exhibit 99.1)가 furnished된 것이며, Exchange Act 제18조의 목적상 'filed'로 간주되지 않으며 Securities Act 관련 제출서류에 참조로 편입되지 않는다고 명시하고 있습니다.

해당 8-K 문서 자체에는 기초가 되는 재무 지표나 운영 세부사항이 포함되어 있지 않으므로 실제 결과는 Exhibit 99.1을 확인해야 합니다. 보고서에는 등록법인의 거래소 상장 증권으로 보통주 CORZ 및 워런트 CORZW, CORZZ가 기재되어 있습니다.

Core Scientific, Inc. a publié un communiqué de presse annonçant ses résultats financiers pour le deuxième trimestre fiscal clos le 30 juin 2025. Le communiqué est fourni en tant que Exhibit 99.1 dans ce Current Report et est incorporé par renvoi aux rubriques 2.02 et 7.01 du dépôt. La société précise que les informations figurant dans les rubriques 2.02 et 7.01, y compris l'Exhibit 99.1, sont furnished et ne doivent pas être considérées comme 'filed' aux fins de la Section 18 de l'Exchange Act, ni incorporées par renvoi dans des dépôts au titre du Securities Act.

Le formulaire 8-K lui-même ne contient pas les indicateurs financiers sous-jacents ni les détails opérationnels ; il convient de consulter l'Exhibit 99.1 pour connaître les résultats effectifs. Le dépôt mentionne également les titres cotés de l'enregistrant : actions ordinaires CORZ et bons de souscription CORZW et CORZZ.

Core Scientific, Inc. hat eine Pressemitteilung mit den Finanzergebnissen für das am 30. Juni 2025 beendete zweite Geschäftsjahrviertel herausgegeben. Die Pressemitteilung ist diesem Current Report als Exhibit 99.1 beigefügt und wird in den Punkten 2.02 und 7.01 der Einreichung durch Verweis aufgenommen. Das Unternehmen erklärt, dass die Informationen in den Punkten 2.02 und 7.01, einschließlich des Exhibit 99.1, als furnished gelten und nicht als 'filed' im Sinne von Section 18 des Exchange Act angesehen werden sollen, noch in Einreichungen nach dem Securities Act durch Verweis aufgenommen werden.

Das 8-K selbst enthält nicht die zugrundeliegenden finanziellen Kennzahlen oder operativen Details; die tatsächlichen Ergebnisse sind dem Exhibit 99.1 zu entnehmen. Die Einreichung nennt außerdem die börsennotierten Wertpapiere des Registranten: Stammaktien CORZ sowie Warrants CORZW und CORZZ.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Furnished Q2 results announced; no numbers in the 8-K, so immediate market impact is neutral until Exhibit 99.1 is reviewed.

The Current Report notifies investors that Core Scientific issued a press release covering results for the quarter ended June 30, 2025, and furnished that release as Exhibit 99.1. Because the 8-K text does not include revenue, profit, cash flow, or guidance figures, it provides notice but no actionable financial detail. The company explicitly states the release is "furnished" and not "filed," which limits incorporation risk. Impact rating: 0

TL;DR The filing is a routine Regulation FD/Item 2.02 disclosure furnishing an earnings release; the form itself reports no material changes.

The report follows standard disclosure practice by furnishing an earnings press release under Items 2.02 and 7.01 and clarifying that the materials are furnished, not filed. As presented, the form does not disclose executive changes, material transactions, or amendments to governance documents. From a governance and compliance perspective the 8-K documents public disclosure without creating new incorporation liabilities. Impact rating: 0

Core Scientific, Inc. ha diramato un comunicato stampa con i risultati finanziari del secondo trimestre fiscale chiuso il 30 giugno 2025. Il comunicato è fornito come Exhibit 99.1 al presente Current Report ed è incorporato per riferimento nelle voci 2.02 e 7.01 della registrazione. La società dichiara che le informazioni contenute nelle voci 2.02 e 7.01, incluso l'Exhibit 99.1, sono furnished e non devono essere considerate 'filed' ai fini della Sezione 18 dello Exchange Act, né incorporate per riferimento in documenti ai sensi dello Securities Act.

L'8-K in sé non riporta i dati finanziari dettagliati o le informazioni operative sottostanti; per i risultati effettivi occorre consultare l'Exhibit 99.1. Il deposito indica inoltre i titoli quotati dell'emittente: azioni ordinarie CORZ e warrant CORZW e CORZZ.

Core Scientific, Inc. difundió un comunicado de prensa con sus resultados financieros del segundo trimestre fiscal finalizado el 30 de junio de 2025. El comunicado se suministra como Exhibit 99.1 a este Current Report y se incorpora por referencia en los ítems 2.02 y 7.01 del expediente. La compañía indica que la información en los ítems 2.02 y 7.01, incluido el Exhibit 99.1, se considera furnished y no debe ser considerada 'filed' a los efectos de la Sección 18 del Exchange Act, ni incorporada por referencia en presentaciones bajo el Securities Act.

El formulario 8-K en sí no contiene las métricas financieras subyacentes ni los detalles operativos; los lectores deben revisar el Exhibit 99.1 para conocer los resultados reales. El informe también enumera los valores cotizados del registrante: acciones ordinarias CORZ y warrants CORZW y CORZZ.

Core Scientific, Inc.는 2025년 6월 30일로 종료된 회계연도 제2분기 재무실적을 알리는 보도자료를 제공했습니다. 해당 보도자료는 본 Current Report의 Exhibit 99.1로 첨부되어 있으며, 제출서류의 항목 2.02 및 7.01에 참조로 포함됩니다. 회사는 항목 2.02 및 7.01에 포함된 정보(및 Exhibit 99.1)가 furnished된 것이며, Exchange Act 제18조의 목적상 'filed'로 간주되지 않으며 Securities Act 관련 제출서류에 참조로 편입되지 않는다고 명시하고 있습니다.

해당 8-K 문서 자체에는 기초가 되는 재무 지표나 운영 세부사항이 포함되어 있지 않으므로 실제 결과는 Exhibit 99.1을 확인해야 합니다. 보고서에는 등록법인의 거래소 상장 증권으로 보통주 CORZ 및 워런트 CORZW, CORZZ가 기재되어 있습니다.

Core Scientific, Inc. a publié un communiqué de presse annonçant ses résultats financiers pour le deuxième trimestre fiscal clos le 30 juin 2025. Le communiqué est fourni en tant que Exhibit 99.1 dans ce Current Report et est incorporé par renvoi aux rubriques 2.02 et 7.01 du dépôt. La société précise que les informations figurant dans les rubriques 2.02 et 7.01, y compris l'Exhibit 99.1, sont furnished et ne doivent pas être considérées comme 'filed' aux fins de la Section 18 de l'Exchange Act, ni incorporées par renvoi dans des dépôts au titre du Securities Act.

Le formulaire 8-K lui-même ne contient pas les indicateurs financiers sous-jacents ni les détails opérationnels ; il convient de consulter l'Exhibit 99.1 pour connaître les résultats effectifs. Le dépôt mentionne également les titres cotés de l'enregistrant : actions ordinaires CORZ et bons de souscription CORZW et CORZZ.

Core Scientific, Inc. hat eine Pressemitteilung mit den Finanzergebnissen für das am 30. Juni 2025 beendete zweite Geschäftsjahrviertel herausgegeben. Die Pressemitteilung ist diesem Current Report als Exhibit 99.1 beigefügt und wird in den Punkten 2.02 und 7.01 der Einreichung durch Verweis aufgenommen. Das Unternehmen erklärt, dass die Informationen in den Punkten 2.02 und 7.01, einschließlich des Exhibit 99.1, als furnished gelten und nicht als 'filed' im Sinne von Section 18 des Exchange Act angesehen werden sollen, noch in Einreichungen nach dem Securities Act durch Verweis aufgenommen werden.

Das 8-K selbst enthält nicht die zugrundeliegenden finanziellen Kennzahlen oder operativen Details; die tatsächlichen Ergebnisse sind dem Exhibit 99.1 zu entnehmen. Die Einreichung nennt außerdem die börsennotierten Wertpapiere des Registranten: Stammaktien CORZ sowie Warrants CORZW und CORZZ.

0001839341FALSECore Scientific, Inc./tx838 Walker RoadSuite 21-2105DoverDelaware00018393412025-08-082025-08-080001839341us-gaap:CommonStockMember2025-08-082025-08-080001839341core:WarrantExercisePriceOf6.81PerShareMember2025-08-082025-08-080001839341core:WarrantExercisePriceOf0.01PerShareMember2025-08-082025-08-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 8, 2025
Core Scientific, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-40046 86-1243837
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
838 Walker Road, Suite 21-2105
Dover, Delaware
 
19904
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (512) 402-5233

(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.00001 per share
CORZ
The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $6.81 per share         
CORZW
The Nasdaq Global Select Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $0.01 per share
CORZZ
The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02    Results of Operations and Financial Condition

On August 8, 2025, the Company issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2025. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01    Regulation FD Disclosure
The information contained in Item 2.02 is incorporated herein by reference.

The information in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01    Financial Statement and Exhibits
(d) Exhibits:
  
Exhibit
No.
Description
99.1
Press Release dated August 8, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document).





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Core Scientific, Inc.
Dated: August 8, 2025
By:/s/ Todd M. DuChene
Name:Todd M. DuChene
Title:Chief Legal Officer and Chief Administrative Officer


FAQ

What did Core Scientific (CORZZ) disclose in this 8-K?

The company furnished a press release announcing financial results for the second fiscal quarter ended June 30, 2025.

Where can I find the press release referenced in the 8-K for CORZZ?

The press release is attached as Exhibit 99.1 to the Current Report dated August 8, 2025.

Is the information in this 8-K "filed" with the SEC?

No. The company states the information in Items 2.02 and 7.01, including Exhibit 99.1, is furnished and shall not be deemed "filed" or incorporated by reference.

Which securities of Core Scientific are listed in this filing?

Common stock: CORZ; Warrants exercisable at $6.81: CORZW; Warrants exercisable at $0.01: CORZZ.

Does the 8-K include financial figures for the quarter?

No. The 8-K references a press release for the quarter's results but does not include the underlying financial metrics in the filing text.
Core Scientific Inc

NASDAQ:CORZZ

CORZZ Rankings

CORZZ Latest News

CORZZ Latest SEC Filings

CORZZ Stock Data

81.99M
Software - Infrastructure
Finance Services
Link
United States
DOVER